Abstract:Mutations of the adenomatous polyposis coli tumor suppressor gene, or its downstream target β‐catenin, have been implicated in the initiation of most sporadic human colorectal epithelial neoplasms. These mutations, in turn, lead to aberrant nuclear accumulation of β‐catenin and subsequent activation of the β‐catenin/Tcf transcription factor complex. In vitro studies utilizing cultured human colon cancer cell lines have identified c‐myc, cyclin D1 and fra‐1 as target genes of β‐catenin/Tcf signaling. In our study, 12 cases of human colorectal adenocarcinomas were examined by Western immunoblotting analysis and immunohistochemical staining to specifically investigate whether the protein expression of these target genes was indeed altered in vivo by β‐catenin dysregulation. The results show that the protein level of β‐catenin was significantly increased in all 12 tumors (3.4 ± 1.0‐fold increase compared to the control normal mucosa by Western immunoblotting, p < 0.05), and this increase was associated with positive nuclear staining by immunohistochemistry in 10 cases. Increased levels of expression of cyclin D1 and Fra‐1 proteins were also demonstrated in every tumor (9.0 ± 2.7 and 3.3 ± 0.9‐fold increases compared to normal mucosa, respectively). Surprisingly, the protein level of c‐Myc was significantly decreased in all tumors examined by 49 ± 19% (p < 0.05), but the c‐myc mRNA level was increased in 8 of 12 tumors when compared to that in normal mucosa by RT‐PCR. Immunohistochemical staining performed on these carcinomas and additional 27 colorectal carcinomas further demonstrated that the protein expression level of c‐Myc and β‐catenin nuclear localization were not correlated. Moreover, 15 of 20 colorectal adenomas exhibited positive nuclear β‐catenin immunostaining, among which 11 also exhibited increased c‐Myc protein expression. These data thus support the notion that upregulation of cyclin D1 and Fra‐1 in human colorectal adenocarcinomas is driven by abnormally expressed β‐catenin. However, the regulation of c‐myc expression in colorectal tumors appears to be more complex. While dysregulated β‐catenin may cause a transcriptional upregulation of the c‐myc gene, the c‐Myc protein expression appears to be further regulated by a posttranscriptional mechanism(s) during the process of neoplastic progression. © 2002 Wiley‐Liss, Inc.

Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Cathelicidin, An Antimicrobial Peptide Produced By Macrophages, Promotes Colon Cancer By Activating The Wnt/Beta-Catenin Pathway

β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer.

C5aR1 is a Master Regulator in Colorectal Tumorigenesis Via Immune Modulation

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Twa1/Gid8 is a Β-Catenin Nuclear Retention Factor in Wnt Signaling and Colorectal Tumorigenesis

Oncogenic Function of DACT1 in Colon Cancer Through the Regulation of Β-Catenin.

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway.

Regulation of the phosphorylation and nuclear import and export of β-catenin by APC and its cancer-related truncated form.

An MST4-pβ-CateninThr40 Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis.

Β‐catenin Regulates IRF3‐mediated Innate Immune Signalling in Colorectal Cancer

Elevated Protein Expression of Cyclin D1 and Fra‐1 but Decreased Expression of C‐myc in Human Colorectal Adenocarcinomas Overexpressing Β‐catenin

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

MACC1 promotes carcinogenesis of colorectal cancer via beta-catenin signaling pathway

Regulation of WNT / β-catenin signaling by carbamoyl-phosphate synthetase 2 , aspartate transcarbamylase , and dihydroorotase ( CAD ) in colorectal cancer cell

Multilevel Regulation of Wnt Signaling by Zic2 in Colon Cancer Due to Mutation of Β-Catenin

β-catenin interacts with and inhibits NF-κB in human colon and breast cancer

An MST4-p-Catenin<SUP>Thr40</SUP> Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis